1/30/2013

Second Sight Medical hopes to raise $25 million in a financing round. The Sylmar, Calif.-based company is awaiting the FDA's decision regarding its Argus II "bionic eye" retinal implant, which has been marketed since March 2011 in Europe.

Related Summaries